MEDICAMEN BIOTECH
Back to Cashflow Statement
|
MEDICAMEN BIOTECH Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹-8.16 Cr | ₹-6.74 Cr | ₹-6.29 Cr | ₹4.11 Cr | ₹13 Cr |
What is the latest Cash Flow from Operating Activities ratio of MEDICAMEN BIOTECH ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹-8.16 Cr |
| Mar2024 | ₹-6.74 Cr |
| Mar2023 | ₹-6.29 Cr |
| Mar2022 | ₹4.11 Cr |
| Mar2021 | ₹13 Cr |
How is Cash Flow from Operating Activities of MEDICAMEN BIOTECH Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-8.16 Cr | Negative | |
| Mar2024 | ₹-6.74 Cr | Negative | |
| Mar2023 | ₹-6.29 Cr | Negative | |
| Mar2022 | ₹4.11 Cr | -67.83 | |
| Mar2021 | ₹13 Cr | - | |
Compare Cash Flow from Operating Activities of peers of MEDICAMEN BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MEDICAMEN BIOTECH | ₹336.3 Cr | 3.3% | 9.5% | -35.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹466,179.0 Cr | -0.4% | 4.3% | 13.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹196,095.0 Cr | 0.9% | 8.9% | 8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,530.0 Cr | 0.7% | 13% | 46.5% | Stock Analytics | |
| CIPLA | ₹114,318.0 Cr | -1% | -0% | -3.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,742.1 Cr | -3.3% | -8.4% | -4.3% | Stock Analytics | |
MEDICAMEN BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MEDICAMEN BIOTECH | 3.3% |
9.5% |
-35.1% |
| SENSEX | -0.6% |
-0.1% |
-6.7% |
You may also like the below Video Courses